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Transcription factorIn cell cultures, the dispersed phenotype is indicative of the migratory ability. Here we characterized
Sal-like 4 (SALL4) as a dispersion factor in basal-like breast cancer. Our shRNA-mediated SALL4
knockdown system and SALL4 overexpression system revealed that SALL4 suppresses the expression
of adhesion gene CDH1, and positively regulates the CDH1 suppressor ZEB1. Cell behavior analyses
showed that SALL4 suppresses intercellular adhesion and maintains cell motility after cell–cell
interaction and cell division, which results in the dispersed phenotype. Our ﬁndings indicate that
SALL4 functions to suppress CDH1 expression and to maintain cell dispersion in basal-like breast
cancer.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cell migration is recognized in various ﬁelds, including cancer.
A hallmark of migratory cells is the dispersed phenotype in
in vitro condition, in which a cell located at the edge of a cluster
loses intercellular adhesion, possesses membrane spikes and
front–rear polarity, and moves away independently from the clus-
ter. In contrast, plated non-migratory cells form compacted clus-
ters, where adhesiveness is augmented, and single dispersed cell
is not seen. One of the phenomena to induce the migratory ability
is epithelial mesenchymal transition (EMT), by which epithelial
properties, e.g., the compacted morphology and epithelial marker
expression, are replaced by the dispersed phenotype and mesen-
chymal gene expression [1]. An advantageous model to study cell
dispersion and EMT is basal-like breast cancer. Some of basal-like
breast cancer cell lines, such as SUM159 and MDA-MB-231, havethe dispersed phenotype and mesenchymal gene expression. These
characteristics are convertible to epithelial properties by genetic
manipulation, which allows us to digest what factor(s) functions
to control cell dispersion and EMT. For instance, the zinc ﬁnger-
and homeobox containing transcription factor ZEB1 (also known
as deltaEF1 and TCF8) acts as an EMT activator. ZEB1 suppresses
the transcription of the adhesion gene CDH1, and ZEB1 knockdown
enhances cell–cell adhesion [2]. The miR200 family of microRNAs
is known as a suppressor of the ZEB family [3]. Introduction of
miR200-mediated ZEB1 silencing diminishes the dispersed pheno-
type and motility in MDA-MB-231 [4]. CDH1 encodes the cell–cell
adhesion protein E-cadherin. MDA-MB-231 having ectopic E-cad-
herin expression exhibits the compacted epithelial morphology
and loss of the migratory ability [5]. These revealed that CDH1 sup-
pression by ZEB1 plays a key role in the maintenance of cell disper-
sion in basal-like breast cancer.
Sal-like 4 (SALL4) is one of the mammalian homologs of the Dro-
sophila region speciﬁc homeotic gene spalt (sal), which encodes a
multiple zinc ﬁnger transcription factor. SALL4 consists of four
exons, and the second of which has an internal splicing donor site.
SALL4A, one of two SALL4 variants, is translated from the mRNA
having the entire exon2, whereas the mRNA for SALL4B has the
short form of exon2 [6]. SALL4 has been identiﬁed as a causative
factor in acute myeloid leukemia [6]. An increase in SALL4
3116 J. Itou et al. / FEBS Letters 587 (2013) 3115–3121expression has also been reported in breast- [7,8], lung- [9], colo-
rectal- [10] and liver cancers [11] as well as germ cell tumors
[12,13]. In addition to in cancerous tissues and cancer cell lines,
SALL4 expression has been detected in circulating breast cancer
cells [14]. In breast cancer cell lines, SALL4 transcription is
positively regulated by STAT3 [7], and SALL4 suppression provides
proliferative inhibition [7,8].
In this study, we identiﬁed SALL4 as a cell dispersion factor. We
demonstrated that basal-like breast cancer cell lines undergo tran-
sition to a compacted epithelial state by SALL4 knockdown. In
reciprocal experiments, the overexpression of SALL4 provided the
dispersed phenotype and a reduction in CDH1 expression to
epithelial cells. The time-course observation revealed that SALL4
prevents cell–cell adhesion, and maintains cell motility in basal-
like breast cancer.
2. Materials and methods
2.1. Cell culture
Basal-like breast cancer cell lines, SUM159 and MDA-MB-231,
were purchased from Asterand (Detroit, MI, USA) and ATCC
(Manassas, VA, USA), respectively. Dr. Robert A. Weinberg kindly
gifted the immortalized human mammary epithelial cells (HMLE)
to us. Details of the culture conditions were described in the Sup-
plementary data. For the wound healing assay, an 80–90% conﬂu-
ent monolayer culture was scratched by a 10–200 ll tip.
2.2. Knockdown and overexpression experiments
Lenti vectors, pLKO.1 (Addgene #10878) and pLKO-TetOn (Add-
gene #21915) were used to express short hairpin RNA (shRNA) and
miR200 family. The sequences of shRNAs are, ‘‘GCGGACUUGAAGA-
AGUCGUGC’’ for shGFP, ‘‘UAGCUUGGCUUGUUUCAAGGC’’ for
shSALL4#3, ‘‘UUACUGUGGCUUCAUCCUCAC’’ for shSALL4#5,
‘‘UUAUAUUCAGUAGUGGUCUGG’’ for shBMI1 and ‘‘UUUAACCU-
CUUGUAUUGUUGC’’ for shZEB1. The retrovirus system with
pMSCV backbone vector (Life Technologies, Carlsbad, CA, USA)
was used to introduce gene overexpression.
2.3. Quantiﬁcation of mRNA level
To evaluate changes in gene transcription, we analyzed the
mRNA levels by quantitative reverse transcription-polymerase
chain reaction (RT-PCR). Total RNA samples were obtained from
cultures with doxycycline (DOX) for 0.5, 1, 2, 4 and 7 days, and
without DOX for 7 days. The primers for mRNA quantiﬁcation are
listed in the Supplementary Table. We used the mean cycle thresh-
old (Ct) values of ACTB and EF1A1 as an internal control, respec-
tively, for the experiments in SUM159 and for in MDA-MB-231
and HMLE. The values of relative mRNA level and standard
deviations were calculated according to the Applied Biosystems’
instruction. For statistical analyses, the deltaCt value, calculated
by subtracting the Ct value of internal control from that of target
gene, was used.
2.4. Immunoblotting
Cells were cultured for 7 days with or without DOX induction
and lysed. Rabbit anti-SALL4 antibody (Abcam, Cambridge, United
Kingdom, ab29112, 1:500), goat anti-ZEB1 antibody (Santa Cruz
Biotechnology, Santa Cruz, CA, USA, sc-10572, E-20, 1:200), rabbit
anti-Cyclin D1 antibody (Cell Signaling Technology, Danvers, MA,
USA, #2978, 92G2, 1:1000) and mouse anti-beta actin antibody
(Abcam, ab6276, 1:2500) were used.2.5. Immunostaining
Cells were cultured for 2 days with or without DOX induction
and ﬁxed. Rabbit anti-E-cadherin antibody (Sigma–Aldrich, Saint
Louis, MO, USA, SAB4503751, 1:100) and goat anti-rabbit IgG anti-
body conjugated with Alexa Fluor 488 (Life Technologies, A11008,
1:2000) were used respectively for the primary and secondary
antibody reactions. DAPI was used for counter staining.
2.6. Luciferase assay
We used luciferase constructs, phosphoglycerate kinase (PGK)
promoter-Luc2, PGK-Luc2-miR200 reporter and ZEB1 promoter-
Luc2. Each luciferase construct was transfected to SUM159, and a
stable cell line was obtained. The stable cells were infected with
the EGFP, miR200 family, shGFP or shSALL4 expression systems,
and cultured for 7 days. The number of cells was counted, and
1  104 cells were used for the assay. The mean value of PGK-
Luc2 stable cells infected with the gene or shRNA expression
system was used to normalize the values of corresponding infec-
tants in the miR200 reporter and ZEB1 promoter assay.
2.7. Imaging
Phase contrast, bright ﬁeld and ﬂuorescent images were
obtained by the all-in-one microscope BZ-9000 Generation II with
BZ Analyzer software (Keyence, Osaka, Japan). For time-lapse anal-
yses, differential interference contrast images were obtained at
every 10 min with an inverted microscope IX81 (Olympus, Tokyo,
Japan). A series of time-lapse images was combined to make a
movie by Metamorph software (Molecular Devices, Sunnyvale,
CA, USA).
2.8. Statistics
Results of cell morphology, mRNA quantiﬁcation and cell
behavior of SALL4 knockdown experiments in SUM159 were statis-
tically analyzed by the one-way ANOVA, because we compared the
value of shSALL4-expressing cells to the values of two controls,
no-DOX and shGFP. Growth, cell death, sequential gene expression
analysis, immunoblotting, luciferase assay, and experiments with
shBMI1 and shZEB1 in SUM159 were analyzed by the Student’s
t-test. The Fisher’s exact test was used for analyses of frequencies
of cell dispersion and adhesion in the time-lapse analyses. Results
of experiments in MDA-MB-231 and HMLE were analyzed by the
Student’s t-test. P < 0.05 was considered statistically signiﬁcant. Er-
ror bars in all graphs indicate standard deviations.
3. Results and discussion
3.1. Epithelial transition is induced by SALL4 knockdown in basal-like
breast cancer
SALL4 involves in cell proliferation in breast cancer cell lines
[7,8]. The functions of SALL4, however, remain elusive. To analyze
the functions of SALL4 in breast cancer, we established a DOX
inducible shRNA expression system with shGFP and shSALL4 con-
structs in the basal-like breast cancer cell line SUM159. To evaluate
effects of our system, we analyzed the cell proliferative ability, a
known function of SALL4. In our system, reduced cell number
was observed in cells having shSALL4#3 and #5 expression, but
not in shGFP expression (Fig. S1A–C). Target sites of shSALL4#3
and #5 were designed at the regions common to the mRNAs of
SALL4 variants. Because the shSALL4#5 is more effective than the
#3, we mainly used the #5 in this study. Quantitative RT-PCR
Fig. 1. The compacted phenotype and epithelial gene expression observed by SALL4
knockdown in SUM159. (A–F) Cell compaction was observed in cells having
shSALL4 expression. Typical images of cells having inducible shGFP (A and B),
shSALL4#3 (C and D) and shSALL4#5 (E and F) are shown. Cells were cultured with
(B, D and F) or without DOX (A, C and E) for 7 days. (G and H) The lengths of
perimeters and contacting areas were measured in the cells located at the edges of
the clusters in the cultures with or without DOX for 7 days. Cells having shSALL4
expression had a shorter perimeter length than control cells (G, n = 30). The ratios of
the lengths of contacting area and perimeter were calculated to analyze the degree
of compaction. Cells having shSALL4 expression were compacted (H, n = 30). (I–K)
mRNA levels were quantiﬁed to analyze changes in the expressions of CDH1 (I,
n = 3), VIM (J, n = 3) and CDH2 (K, n = 3) in the cultures with or without DOX for
7 days. (L–O) Immunostaining was performed in shGFP (L and M, n = 3) and
shSALL4 (N and O, n = 3). Cells were cultured with (M and O) or without DOX (L and
N) for 2 days. Detectable E-cadherin expression (green) was observed in shSALL4-
expressing cells. Nuclei were visualized by DAPI (blue). The inset in O is a high
magniﬁcation image of the boxed area. Scale bars in A–F and L–O indicate 100 lm.
Error bars indicate standard deviations. Asterisks indicate statistical signiﬁcance.
(For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
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mRNA and protein levels in DOX-induced cells (Fig. S1D and E).
The ratio between the numbers of dead cells and total cells in
shSALL4-expressing cells was identical to that in the no-DOX con-
trol (Fig. S1F), indicating that the reduced cell number observed by
SALL4 knockdown is not due to decreased cell survival. To analyze
changes in expression of the proliferation genes, we quantiﬁed the
mRNA levels. BMI1, a polycomb group gene, is positively regulated
by SALL4 [15]. BMI1 suppresses expression of the cyclin-dependent
kinase inhibitors, such as p16, p18 and p21 [16]. In our system,
shSALL4 reduced the BMI1 level and increased the p16 and p18 lev-
els (Fig. S2A–D). We analyzed other proliferation markers, MYC,
CCNE1 and CCND1. It has been reported that SALL4 positively reg-
ulates CCND1 in transcription level [11]. We observed a reduction
in expression of CCND1 in shSALL4-expressing cells (Fig. S2E–G).
In protein analysis, Cyclin D1, the product of CCND1, level was re-
duced (Fig. S2H). These results indicate that SALL4 regulates cell
proliferation in breast cancer, and our inducible shRNA expression
system is useful to explore SALL4 functions.
In in vitro conditions, some of basal-like breast cancer cell lines,
including SUM159, tend to be dispersed. Surprisingly, almost cells
having shSALL4 expression lost membrane spikes, and formed
compacted clusters (Fig. 1A–F). In order to examine this difference,
we measured the lengths of perimeters and contacting areas of
cells located at the edges of the clusters (Fig. S3). Polarized and
spine-rich cells typically have a longer perimeter than spineless
cells. We compared the lengths of perimeters of shSALL4-express-
ing cells to that of no-DOX and shGFP controls. Small values ob-
served in shSALL4-expressing cells indicate that the cells became
spineless (Fig. 1G). The ratio of the length of contacting area to that
of perimeter reﬂects the degree of compaction. Cells having
shSALL4 expression were more compacted than the controls
(Fig. 1H).
Since mammary cells possess a potential to shift between com-
pacted epithelial and dispersed mesenchymal states [2,17], the
compaction observed in shSALL4-expressing cells was suggestive
of a transition to the epithelial state. Thus, we analyzed mRNA lev-
els of the epithelial marker CDH1 and the mesenchymal markers
VIM and CDH2 (Fig. 1I–K). In shSALL4-expressing cells, the CDH1 le-
vel was increased and the VIM level was reduced. The CDH2 level
was not signiﬁcantly changed. We detected immunoreaction of
E-cadherin, the product of CDH1, in shSALL4-expressing cells
(Fig. 1L–O). Our observations, the compacted phenotype (Fig. 1D,
F and H) and the up-regulation of epithelial marker CDH1 (Fig. 1I
and O), indicate that SALL4 knockdown induces the epithelial tran-
sition. The previous study has demonstrated that ectopic E-cad-
herin expression induces the compacted phenotype and
reduction in the vimentin, the product of VIM, level in basal-like
breast cancer MDA-MB-231 [5]. SALL4 might regulate cell disper-
sion and mesenchymal gene expression by suppressing CDH1
transcription.
3.2. SALL4 regulates the EMT factor ZEB1
We suspected that SALL4 regulates transcription factors involv-
ing in EMT, because SALL4 knockdown induces epithelial
transition. In order to identify the factor(s), we used quantitative
RT-PCR to screen the transcription factors, SNAI1, SNAI2, TWIST1,
TWIST2, FOXC1, FOXC2, TGFB1, TCF3, GSC, GRHL2, ZEB1 and ZEB2
[18–20]. In the result, we found reduction in the ZEB1 mRNA level
in shSALL4-expressing cells (Fig. 2A), while the others were not sig-
niﬁcantly changed (Fig. 2B and Fig. S4). No detectable ampliﬁcation
was observed in the experiments for GSC and GRHL2. In addition to
change in the ZEB1 mRNA level, ZEB1 protein level was reduced in
shSALL4-expressing cells (Fig. S5).ZEB1 mRNA is one of known targets of the miR200 family-med-
iated gene silencing [4,21]. Thus we assessed the activities of
miR200s by using a miR200 reporter (Fig. S6), which has the
ZEB1 30 untranslated region, a target of miR200 family. To evaluate
the miR200 reporter, we introduced expressions of two miR200 re-
gions, miR200b-a-429 and miR200c-141. The expression of
miR200 family decreased the luciferase activity (Fig. 2C), indicating
that using the miR200 reporter enables us to examine the activities
of miR200s-mediated gene silencing. Comparing to the shGFP con-
trol, shSALL4-expressing cells showed no alteration of the lucifer-
ase activity (Fig. 2D). This result indicates that the activities of
miR200s are not changed by SALL4 knockdown. It is known that
expressions of the ZEB family and the miR200 family are mutually
exclusive [3]. ZEB1 and ZEB2 bind to the promoter regions of
miR200 family, and suppress their transcription. The miR200s act
as the silencer for ZEB1 and ZEB2 mRNAs by binding to their 30
untranslated regions. A previous study has demonstrated that
ZEB1 knockdown increases miR200s activities [22]. We showed
Fig. 2. The SALL4-ZEB1 network in SUM159. (A and B) Quantiﬁcation of the
expression levels of ZEB family transcription factors at 7 days post DOX adminis-
tration. ZEB1 expression was reduced by shSALL4 expression (A, n = 3), whereas
ZEB2 was not affected (B, n = 3). (C and D) The activity of the miR200 reporter was
reduced by the miR200 family expression (C, n = 3), but not by shSALL4 (D, n = 3).
(E) ZEB1 promoter activity was reduced by shSALL4 expression (n = 3). (F–H) The
levels of mRNA were quantiﬁed for BMI1 (F, n = 3), ZEB1 (G, n = 3) and CDH1 (H,
n = 3) in the cells having DOX inducible shBMI1 expression. (I–K) The levels of
mRNA were quantiﬁed for BMI1 (I, n = 3), ZEB1 (J, n = 3) and CDH1 (K, n = 3) in the
cells having shGFP or shZEB1 expression. Error bars indicate standard deviations.
Asterisks indicate statistical signiﬁcance.
Fig. 3. Sequential gene expression changes after SALL4 knockdown in SUM159. (A–
C) Quantiﬁcation of the mRNA levels for SALL4 (A, n = 3), ZEB1 (B, n = 3) and CDH1 (C,
n = 3) were performed at 0.5, 1, 2 and 4 days. The same values of no-DOX controls as
for the analyses shown in Fig. S1 (SALL4), Fig. 2 (ZEB1) and Fig. 1 (CDH1) were used
to calculate relative values. Error bars indicate standard deviations. Asterisks
indicate statistical signiﬁcance. Data between the no-DOX control and each time
point were analyzed by the Student’s t-test.
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were not increased (Fig. 2D). No alteration of miR200s activity ob-
served in shSALL4-expressing cells is likely due to the function of
another miR200s suppressor ZEB2, the mRNA level of which was
not changed by SALL4 knockdown (Fig. 2B). A similar observation
has been reported in a study in ovarian cancer, which showed that
the miR200c-141 level was not altered by ZEB1 knockdown in cells
expressing ZEB2 [23]. To analyze whether ZEB1 promoter activity
was affected by SALL4 knockdown, we connected the 5 kbp up-
stream region of the ZEB1 initiation codon to the luciferase2 gene
(Fig. S6). Cells having this ZEB1 promoter construct showed a
reduction in the luciferase activity when shSALL4 was expressed
(Fig. 2E), suggesting that SALL4 positively regulates ZEB1
transcription.
Our results demonstrated that SALL4 regulates two transcrip-
tional regulators, BMI1 (Fig. S2A) and ZEB1 (Fig. 2A). To analyze
whether BMI1 regulates ZEB1 transcription, we performed shRNA-
mediated BMI1 knockdown assays. Due to severe proliferative
inhibition of BMI1 knockdown [16], we could not obtain enough
number of shBMI1 infectants to analyze the gene expression. We
therefore established the DOX inducible shBMI1 expression system
to obtain a sufﬁcient number of cells with avoiding the proliferative
inhibition. The ZEB1 mRNA level was not changed by shBMI1induction (Fig. 2F and G). In head and neck squamous cell carci-
noma, CDH1 transcription is suppressed by BMI1, and BMI1 knock-
down increases the E-cadherin level [24]. In basal-like breast
cancer, however, the CDH1mRNA level was not affected by shBMI1
expression (Fig. 2H). This suggests that themechanism of CDH1 reg-
ulation is different among cell types.
Besides analyses in shBMI1 expressing cells, we performed ZEB1
knockdown experiments. The BMI1mRNA level was not affected by
ZEB1 knockdown (Fig. 2I and J). The results of ZEB1 and BMI1
knockdown experiments suggest that these transcriptional regula-
tors are independently regulated by SALL4. Since ZEB1 acts as the
suppressor for CDH1 transcription [2], the CDH1 mRNA level was
up-regulated by shZEB1 expression (Fig. 2K). This suggests that
the SALL4-ZEB1 network regulates CDH1 transcription.
If CDH1 transcription is suppressed by the SALL4-ZEB1 network,
a change in CDH1 level should be observed after a reduction in ZEB1
expression when shSALL4 is induced. To analyze the timing of
changes in SALL4, ZEB1 and CDH1 expressions, we performed quan-
titative RT-PCR in the DOX inducible shSALL4 expression system at
time points 0.5, 1, 2 and 4 days post DOX administration. A reduc-
tion in the SALL4 mRNA level was observed from 0.5 day (Fig. 3A).
The ZEB1 level was signiﬁcantly changed from 1 day (Fig. 3B). An in-
crease in the CDH1 level was observed from 2 days, suggesting that
up-regulation of CDH1 transcription occurs between 1 and 2 days
(Fig. 3C). These results support the suggestion that CDH1 is sup-
pressed by the SALL4-ZEB1 network in basal-like breast cancer.
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MDA-MB-231 as well as in SUM159
The previous study has reported that SALL4 knockdown impairs
the proliferative ability in another basal-like breast cancer cell line
MDA-MB-231 [7]. To assess the generality of our observation in
SUM159, we analyzed the changes in the phenotype and gene
expression in MDA-MB-231. Cells having shSALL4 expression lost
spikes and exhibited an oval-shape (Fig. 4A and B). However, un-
like SUM159, the cells were enlarged. The mean perimeter length
of enlarged oval-shaped cells was comparable to that of spine-rich
controls (Fig. 4C). SALL4 knockdown increased the degree of com-
paction in MDA-MB-231 (Fig. 4D). In quantitative RT-PCR analyses
for the epithelial and mesenchymal genes, CDH1 expression was
augmented, and VIM was reduced (Fig. 4E and F). The CDH2 level
was not signiﬁcantly changed (Fig. 4G). The levels of transcrip-
tional regulators BMI1 and ZEB1 were reduced by SALL4 knock-
down (Fig. 4H and Fig. S7). These results, except for the effect on
cell size, were similar to the observations in SUM159, suggesting
that SALL4 maintains cell dispersion and regulates the expressions
of epithelial and mesenchymal genes in basal-like breast cancer
cell lines.Fig. 4. The compacted phenotype and changes in gene expressions observed by
SALL4 knockdown in MDA-MB-231. (A and B) Compaction was seen in cells having
shSALL4 expression at 7 days post infection. Typical images of cells having shGFP
(A) and shSALL4 (B) are shown. Scale bars indicate 100 lm. (C and D) The lengths of
perimeters and contacting areas were measured in the cells located at the edges of
the clusters. The perimeter lengths were not changed (C, n = 30). Cells having
shSALL4 expression were compacted (D, n = 30). (E–H) Total mRNA was obtained at
7 days post infection, and cDNA was synthesized. The levels of mRNA were
quantiﬁed to analyze changes in expressions of CDH1 (E, n = 3), VIM (F, n = 3), CDH2
(G, n = 3) and ZEB1 (H, n = 3). Error bars indicate standard deviations. Asterisks
indicate statistical signiﬁcance.3.4. Mammary epithelial cells exhibit the dispersed phenotype and
express the mesenchymal genes by SALL4 overexpression
HMLE is utilized as an epithelial cell model in breast cancer
studies [17]. We overexpressed SALL4 variants, SALL4A and
SALL4B, in HMLE to analyze whether SALL4 induces cell dispersion
in compacted epithelial cells. The EGFP control showed compacted
clusters (Fig. 5A). The clusters of SALL4A and SALL4B overexpress-
ing cells had more spaces than that of EGFP control (Fig. 5B and C
arrowheads). These spaces were likely to be caused by a loss of
adhesiveness. In SALL4 overexpressions, cells exhibited membrane
spikes, and the mean lengths of perimeters were increased
(Fig. 5D). The degrees of compaction were reduced (Fig. 5E). These
results imply that SALL4 forces cell dispersion in HMLE. However,
SALL4 itself is insufﬁcient to induce complete cell dispersion as in
basal-like breast cancers, suggesting that other supportive factor(s)
is required to induce it.
In basal-like breast cancers, SALL4 knockdown increases the
expression of adhesion gene CDH1 and reduces the levels of mesen-
chymal genes VIM and ZEB1 (Figs. 1, 2 and 4). We analyzed the
mRNA levels of CDH1, VIM and ZEB1 in HMLE having SALL4 overex-
pression. SALL4A and SALL4B reduced the CDH1 level (Fig. 5F),
which might involve in a loss of cell–cell adhesion. Conversely,
the VIM and ZEB1 expressions were up-regulated (Fig. 5G and H).Fig. 5. The dispersed phenotype and mesenchymal gene expression induced by
SALL4 overexpression in epithelial cells. (A–C) Typical images of EGFP (A), SALL4A
(B) and SALL4B (C) overexpressing epithelial cells. Spaces in clusters were pointed
by arrowheads. A0 , B0 and C0 are the high magniﬁcation images of the boxed areas of
A, B and C, respectively. Scale bars indicate 100 lm. (D and E) The lengths of
perimeters and contacting areas were measured in the cells located at the edges of
the clusters. SALL4 overexpressing cells had a longer perimeter than the EGFP
control (D, n = 30). The ratios of the contacting area length to the perimeter length
were smaller in cells having SALL4 overexpression than in the EGFP control (E,
n = 30). (F–H) The levels of mRNA were quantiﬁed to analyze changes in the
expressions of CDH1 (F, n = 3), VIM (G, n = 3) and ZEB1 (H, n = 3) by SALL4
overexpression. Error bars indicate standard deviations. Asterisks indicate statis-
tical signiﬁcance.
Fig. 6. Attenuation of the dispersion ability in shSALL4-expressing SUM159. (A)
Serial pictures of time-lapse microscopy of control (top) and shSALL4-expressing
cells (bottom) are shown. Yellow and blue arrowheads point to the contacting state
and dispersion, respectively. Arrows indicate the traced cells. Scale bars indicate
100 lm. (B and C) The numbers of occurrences of cell dispersion and adhesion were
counted after cell–cell interaction (B, n = 233 interactions in DOX(), n = 239
interactions in DOX(+)) and cell division (C, n = 118 divisions in DOX(), n = 113
divisions in DOX(+)). Asterisks indicate statistical signiﬁcance.
Fig. 7. Loss of migratory ability in compacted shSALL4-expressing SUM159. (A–H)
The wound healing assay was performed in shGFP (A, B, E and F)) and shSALL4 (C, D,
G and H). Cells were cultured with (B, D, F and H) or without DOX (A, C, E and G) for
7 days. Scratched cultures were stained by crystal violet, and typical images are
shown. Dashed lines are depicted to indicate scratched areas. Scale bars indicate
100 lm. (I) The number of cells located in the scratched areas was counted at 12
and 24 h (n = 6 positions). Error bars indicate standard deviations. Asterisks indicate
statistical signiﬁcance.
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phenotype in basal-like breast cancers, SALL4 is capable of inducing
cell dispersion with a reduction in CDH1 expression and an increase
in the transcription of mesenchymal genes in epithelial cells. Given
that SALL4 up-regulates the ZEB1 transcription (Figs. 2A and E, 4H,
5H), and that ZEB1 suppresses the CDH1 transcription (Fig. 2K) [2],
the down-regulation of CDH1 was likely to be caused by an ectopic
activation of SALL4-ZEB1 network. Since loss of CDH1 function
diminishes intercellular adhesiveness in HMLE [25], CDH1 suppres-
sion by the SALL4-ZEB1 network might result in a loss of adhesive-
ness. We observed identical effects between the SALL4A and
SALL4B overexpressions in HMLE, indicating that the regulation of
cell dispersion is a fundamental function of SALL4.
3.5. SALL4 suppresses cell–cell adhesion to maintain cell dispersion in
basal-like breast cancer
Cells having shSALL4 expression exhibited compacted clusters
(Fig. 1D and F), suggesting that SALL4 knockdown changes cell
behavior. Time-lapse microscopy is utilized to explore cell move-
ments.We performed the time-lapse analyses from 1 to 2 days after
starting incubation with DOX in which compaction is initiated in
our SALL4 knockdown system. The up-regulation of CDH1 tran-
scription is also initiated between 1 and 2 days post DOX adminis-
tration (Fig. 3C). The no-DOX controls repeated contact and
dispersion (Movie S1). For instance, as shown in Fig. 6A top, one cell
interacted with another cell at time point 20 min, and the contact
was preserved until 120 min. At 140 min, the cells were uncoupled.
Subsequently, one uncoupled cell collided with the other cell at
160 min, and dispersed immediately. In comparison to the control,
the contacting period of the cell having shSALL4 expression was ex-
tended (Fig. 6A bottom, Movie S2). Cells were interacted at 20 min,
and adhered. This contact was persisted for longer than 200 min.
For further understanding of the behavior, we compared the
frequencies of cells immediately dispersed, dispersed in 1, 3 and
5 h, and adhered longer than 5 h after cell–cell interaction
(Fig. 6B). Most of the control cells were dispersed within 5 h after
interaction (78.11%). In shSALL4-expressing cells, the frequencies
of dispersion within 5 h were decreased (48.12%), and the rate of
formation of intercellular adhesion was increased (21.89–
51.88%). In addition, we analyzed the frequencies after cell division
(Fig. 6C). Similarly to the results of after cell–cell interaction, the
frequencies of dispersion within 5 h were reduced (24.57–5.31%).
These suggest that SALL4 knockdown impairs the dispersion ability
by enhancing intercellular adhesiveness.
We asked whether shSALL4-expressing cells do not disperse
from highly compacted clusters, and whether the compacted clus-
ters move around. We performed the wound healing assay in 80–
90% conﬂuent cultures with the proliferation inhibitor mitomycin
C (Fig. 7). Because the proliferative ability is different between the
control and shSALL4-expressing cells (Fig. S1), inhibition of prolifer-
ation was demanded to count the exact number of cells moved into
the scratched areas, and to analyze the dispersion ability in the
wound healing assay. To determine the concentration of mitomycin
C, we performed a growth assay, and found that 0.5 lg/ml of it suf-
ﬁciently inhibited cell proliferation (Fig. S8). In controls, cells were
dispersed and ﬁlled the scratched areas (Fig. 7E–G). However the
number of cells in the scratched areas was signiﬁcantly reduced
in shSALL4-expressing cells (Fig. 7H and I), indicating that
shSALL4-expressing cells do not disperse from their cluster, and
that the compacted cluster is immobile. We, moreover, analyzed
the speeds of movement in the time-lapsemovies used for the anal-
yses shown in Fig. 6. The mean and maximum speeds were not
changed between single cells with and without shSALL4 expression
(Fig. 8A and B, single). We also analyzed the motility of cells in
contact with other cell(s). Although the no-DOX control had an
Fig. 8. Attenuation of the motility in contacting shSALL4-expressing SUM159. (A
and B) The mean (A) and maximum moving speeds (B) are presented. The moving
speed was analyzed in single cell with (n = 35) or without DOX (n = 32), and in
contacting cell with (n = 40) or without DOX (n = 36). Error bars indicate standard
deviations. Asterisks indicate statistical signiﬁcance.
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showed reduced moving speeds (Fig. 8A and B contacting). The
attenuation of the motility observed in contacting shSALL4-
expressing cells is consistent with the results of the wound healing
assay, and suggests that the trigger to lose cell motility is intercel-
lular adhesion.
We showed that the ability of cell–cell adhesion after interaction
and cell division was enhanced in shSALL4-expressing cells
(Fig. 6A–C). In epithelial cells, the adhesion protein E-cadherin
localizes in the contacting area to form cell–cell adhesion after
interaction [26]. Our immunostaining for E-cadherin showed strong
signals in the contacting areas (Fig. 1O), supporting the notion that
cell–cell adhesion is enhanced by SALL4 knockdown. As exempli-
ﬁed by the wound healing assay and the analysis of moving speeds
(Figs. 7 and 8), intercellular adhesion observed in shSALL4-express-
ing cells persists for more than 24 h, and adhered cells loses their
motility. Accumulation of the low-motile adhered cells could devel-
op to compacted clusters. Taken together, SALL4 functions to sup-
press the formation of cell–cell adhesion to preserve cell motility
when cells interact, which contributes to the dispersed phenotype.
In this study, we identiﬁed SALL4 as the cell dispersion factor.
SALL4 suppresses the adhesion gene CDH1, and positively regulates
the CDH1 suppressor ZEB1. Consistent with the previous study [5],
basal-like breast cancer having shSALL4-induced CDH1 expression
lost the dispersed phenotype. The STAT3 inhibitor impairs the dis-
persion ability in glioma cells [27]. Given that STAT3 is a positive
regulator for SALL4 transcription in breast cancer [7], our ﬁndings
are in agreement with the report in glioma cells. Dispersion from
an adhesive cluster is one of the characteristics of metastatic can-
cer [28]. Some of compacted cancer cells acquire the motility and
migrate from a cluster to a distant site. Similar events are known
in other research ﬁelds, such as migratory neural crest cells in
development [29] and cardiomyocyte migration in regeneration
[30]. Therefore, this study might not only contribute to therapies
for cancer metastasis, but also facilitate understanding of the nat-
ure of cell migration.
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